Safety and efficacy of intravenous colistin in children

被引:0
作者
Poddutoor Preetham Kumar
Swapnil Rameshwar Giri
Farhan A. R. Shaikh
Nalinikant Panigrahy
Dinesh Chirla
机构
[1] Rainbow Children’s Hospital,Department of Intensive Care
来源
Indian Pediatrics | 2015年 / 52卷
关键词
Acute kidney injury; Antimicrobial resistance; Colistin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:129 / 130
页数:1
相关论文
共 61 条
  • [1] Kumarasamy KK(2010)Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study Lancet Infect Dis. 10 597-602
  • [2] Toleman MA(2007)Extended spectrum beta-lactamase-producing Klebsiella pneumoniae from blood culture J Med Microbiol. 56 999-1000
  • [3] Walsh TR(2008)Polymyxins revisited Clin Microbiol Rev. 21 449-65
  • [4] Bagaria J(2012)The use of intravenous colistimethate sodium among children in the United States: Results from a multicenter case series Pediatr Infect Dis J. 32 17-22
  • [5] Butt FA(2009)Systemic colistimethate sodium use in children without cystic fibrosis: A systematic review of the literature Int J Antimicrob Agents. 33 1-13
  • [6] Balakrishnan R(2010)Colistimethate sodium administration to pediatric and neonatal patients Eur J Pediatr. 169 867-74
  • [7] Harish BN(2011)Modified RIFLE criteria in critically ill children with acute kidney injury Pediatr Infect Dis J. 30 218-21
  • [8] Menezes GA(2007)Intravenou colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients Kidney Int. 71 1028-35
  • [9] Shekatkar S(2013)Use of colistimethate sodium in a pediatric burn unit in Argentina Pediatr Crit Care Med. 14 268-72
  • [10] Parija SC(2009)Intravenous colistimethate (colistimethate sodium) use in critically ill children without cystic fibrosis J Burn Care Res. 30 612-5